Mar 23, 2013 by Max Macaluso3 Health Care Companies Unlocking the Fountain of YouthKim Kardashian's "Vampire Facelift" may be dominating the headlines, but can investors profit from beauty treatments?
Mar 22, 2013 by Max MacalusoIs Obesity Really a Dangerous Disease?How do clinicians define this disease, and what other diseases can obesity lead to?
Mar 22, 2013 by Max MacalusoBiogen’s Revolutionary Multiple Sclerosis Treatment Clears First HurdleBiogen's MS drug Tecfidera (formerly known as BG-12) got the green light from the EU's CHMP; could FDA approval be next?
Mar 22, 2013 by Max MacalusoEU Deja Vu for This Biotech’s Orphan DrugThe EU's CHMP does not recommend Isis Pharmaceuticals and Sanofi's drug Kynamro ... for the second time.
Mar 22, 2013 by Max MacalusoAriad's Potential Blockbuster Set for EU DebutAriad's FDA approved drug Iclusig looks set to gain EU approval.
Mar 21, 2013 by Max MacalusoA Revolutionary Diabetes Drug You Need to WatchNovo Nordisk's new diabetes drug could offer patients a more convenient way to take insulin, but development will take a few more years.
Mar 18, 2013 by Max MacalusoIs This an Obesity-Drug Success or Failure?Novo Nordisk announced today that its drug met primary endpoints in a phase 3 study -- so why were shares down?
Mar 18, 2013 by Max MacalusoNovartis' Life-Changing Blockbuster DrugDr. Margaret I. Cuomo and Max Macaluso discuss why Novartis' Gleevec was a major scientific breakthrough, and why some types of cancer are more difficult to treat than others.
Mar 18, 2013 by Max MacalusoIs This Drugmaker Making the Right Moves, in the Right Places?AstraZeneca announced that it will move its headquarters to Cambridge, England. Is this the right move?
Mar 18, 2013 by Max MacalusoCancer Prevention and the Hidden Risk of ObesityObesity is typically associated with heart problems and diabetes, but can it also lead to cancer?
Mar 14, 2013 by Max MacalusoThe Biggest Threat to Merck's Blockbuster?Merck's HPV vaccine Gardasil has reached blockbuster status, but are there threats to its market dominance?
Mar 13, 2013 by Max MacalusoMerck's Companion in the Fight Against Alzheimer'sThe big pharma company is taking another step forward in its battle.
Mar 12, 2013 by Max MacalusoWhat Do Snake Venom, Tree Bark, and Drugs Have in Common?Have you ever wondered where over-the-counter and prescription drugs actually come from?
Mar 12, 2013 by Max MacalusoDoes MannKind Have the Wrong Strategy?Why biotech company MannKind should have actually been conceived as a medical device company.
Mar 8, 2013 by Max Macaluso1 Way to Prevent Cancer TodayDr. Margaret I. Cuomo discusses one way savvy consumers can lower their risk of developing cancer today.
Mar 8, 2013 by Max MacalusoIs This Cancer Drug Really a Vaccine?Does this vaccine help prevent prostate cancer --- or treat it?
Mar 8, 2013 by Max MacalusoWill This Drugmaker Hit a Roadblock?Could a drug recall be coming for Merck after new report points to increased risk of pancreatitis?
Mar 7, 2013 by Max MacalusoIs Merck Changing Its Strategy?Merck is bringing in an R&D executive; could investors see big changes up ahead?
Mar 7, 2013 by Max MacalusoThis Obesity Biotech Is Going MobileObesity drugmaker VIVUS is hoping to create more buzz with a mobile app.
Mar 6, 2013 by Max MacalusoA World Without Cancer: Is Prevention the Cure?One Foolish health care analyst sits down with Dr. Margaret I. Cuomo, author of "A World Without Cancer."
